Essential Planning, Llc. Ionis Pharmaceuticals Inc Transaction History
Essential Planning, Llc.
- $15 Billion
- Q4 2024
A detailed history of Essential Planning, Llc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Essential Planning, Llc. holds 11,440 shares of IONS stock, worth $352,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,440Holding current value
$352,809% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
414Shares Held
137MCall Options Held
859KPut Options Held
617K-
Vanguard Group Inc Valley Forge, PA16.5MShares$508 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$437 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$318 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$267 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$243 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.38B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...